NVS - Novartis AG (NVS) CEO Vas Narasimhan on Q3 2021 Results - Earnings Call Transcript

Novartis AG (NVS) Q3 2021 Earnings Conference Call October 26, 2021, 08:00 AM ET Company Participants Vas Narasimhan – Chief Executive Officer Samir Shah – Global Head of Investor Relations Harry Kirsch – Chief Financial Officer Marie France – President of Novartis Pharmaceuticals Susanne Schaffert – President of Novartis Oncology John Tsai – Head of Global Drug Development and Chief Medical Officer Richard Saynor – Chief Executive Officer Karen Hale – Chief Legal Officer Conference Call Participants Graham Parry – Bank of America Peter Welford – Jefferies Andrew Baum – Citi Laura Sutcliffe – UBS Simon Baker – Redburn Keyur Parekh – Goldman Sachs Seamus Fernandez – Guggenheim Security Sureta Capilla (Ph) – Morgan Stanley Jo Walton – Credit Suisse Richard Buffett – JP Morgan Richard Parkes – Exane BNP Paribas Naresh Chouhan – Intron Health Florent Cespedes – SocGen Richard Wagner – Wolfe Research Wimal Kapadia – Bernstein Emmanuel

For further details see:

Novartis AG (NVS) CEO Vas Narasimhan on Q3 2021 Results - Earnings Call Transcript